company background image
ISRG

Intuitive SurgicalNasdaqGS:ISRG Stock Report

Market Cap

US$114.3b

7D

-3.6%

1Y

29.4%

Updated

02 Dec, 2021

Data

Company Financials +
ISRG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends0/6

ISRG Stock Overview

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally.

Rewards

Earnings are forecast to grow 10.4% per year

Earnings grew by 60.4% over the past year

Risk Analysis

No risks detected for ISRG from our risk checks.

Intuitive Surgical Competitors

Medtronic

NYSE:MDT

US$141.8b

Edwards Lifesciences

NYSE:EW

US$67.1b

IDEXX Laboratories

NasdaqGS:IDXX

US$50.8b

ResMed

NYSE:RMD

US$36.9b

Price History & Performance

Summary of all time highs, changes and price drops for Intuitive Surgical
Historical stock prices
Current Share PriceUS$327.32
52 Week HighUS$369.69
52 Week LowUS$227.47
Beta1.05
1 Month Change-9.17%
3 Month Change-8.38%
1 Year Change29.42%
3 Year Change89.17%
5 Year Change375.56%
Change since IPO16,209.37%

Recent News & Updates

Nov 23

Intuitive Is Still A Buy But With New Risks That Require Attention

Intuitive Surgical is firing on all cylinders and faces medium-term tailwinds. The company seems to have navigated through the worst of its supply chain issues but faces new risks that could materially deter the long thesis. Investors manage actively. The stock is a buy as it justifies its above valuation with above-average financials and results.

Nov 19
Do Intuitive Surgical's (NASDAQ:ISRG) Earnings Warrant Your Attention?

Do Intuitive Surgical's (NASDAQ:ISRG) Earnings Warrant Your Attention?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Oct 17

Intuitive Surgical: Future Of Health Care

U.S. surgical robotic market is expected to grow at 20.1% CAGR over the next several years, and ISRG will get a huge tailwind from this growth. ISRG is practically printing money, with a large pile of cash accumulated in cash & short-term investments ($4.43 B). With a market cap over $100 B, ISRG needs to expand its horizons to reach the next level.

Oct 05
With an Understated 30% Profit Margin, Intuitive Surgical, Inc. (NASDAQ:ISRG) may be a Great Find for Investors

With an Understated 30% Profit Margin, Intuitive Surgical, Inc. (NASDAQ:ISRG) may be a Great Find for Investors

Intuitive Surgical (NASDAQ:ISRG). But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to study Intuitive Surgical's ROE and future growth in this article.

Sep 21

Intuitive Surgical: Alpha Opportunity

Intuitive Surgical is benefiting from pandemic-driven tailwinds. Company has a heavy backlog of procedures that will enable it to prosper during reopening. There will also a higher run rate of demand. The consensus of analyst estimates does not reflect this outcome. I do not see the lofty valuation of Intuitive Surgical as a deterrent to my Buy recommendation given the near-term earnings upside, secular tailwinds behind the company, and its exceptional financial profile.

Shareholder Returns

ISRGUS Medical EquipmentUS Market
7D-3.6%-3.0%-3.5%
1Y29.4%11.7%19.4%

Return vs Industry: ISRG exceeded the US Medical Equipment industry which returned 9.5% over the past year.

Return vs Market: ISRG exceeded the US Market which returned 17.8% over the past year.

Price Volatility

Is ISRG's price volatile compared to industry and market?
ISRG volatility
ISRG Average Weekly Movement3.6%
Medical Equipment Industry Average Movement7.5%
Market Average Movement6.1%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: ISRG is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ISRG's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19958,081Gary Gutharthttps://www.intuitive.com

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company’s da Vinci Surgical System include surgeon’s consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates.

Intuitive Surgical Fundamentals Summary

How do Intuitive Surgical's earnings and revenue compare to its market cap?
ISRG fundamental statistics
Market CapUS$114.29b
Earnings (TTM)US$1.69b
Revenue (TTM)US$5.49b

69.2x

P/E Ratio

21.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ISRG income statement (TTM)
RevenueUS$5.49b
Cost of RevenueUS$1.70b
Gross ProfitUS$3.79b
ExpensesUS$2.10b
EarningsUS$1.69b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)4.73
Gross Margin69.12%
Net Profit Margin30.78%
Debt/Equity Ratio0.0%

How did ISRG perform over the long term?

See historical performance and comparison

Valuation

Is Intuitive Surgical undervalued compared to its fair value and its price relative to the market?

69.22x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ISRG ($327.32) is trading above our estimate of fair value ($222.54)

Significantly Below Fair Value: ISRG is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ISRG is poor value based on its PE Ratio (69.2x) compared to the US Medical Equipment industry average (45.4x).

PE vs Market: ISRG is poor value based on its PE Ratio (69.2x) compared to the US market (16.6x).


Price to Earnings Growth Ratio

PEG Ratio: ISRG is poor value based on its PEG Ratio (6.7x)


Price to Book Ratio

PB vs Industry: ISRG is overvalued based on its PB Ratio (10.2x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is Intuitive Surgical forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

10.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ISRG's forecast earnings growth (10.4% per year) is above the savings rate (2%).

Earnings vs Market: ISRG's earnings (10.4% per year) are forecast to grow slower than the US market (14.3% per year).

High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.

Revenue vs Market: ISRG's revenue (12.1% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: ISRG's revenue (12.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (14.4%).


Past Performance

How has Intuitive Surgical performed over the past 5 years?

15.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ISRG has high quality earnings.

Growing Profit Margin: ISRG's current net profit margins (30.8%) are higher than last year (24.5%).


Past Earnings Growth Analysis

Earnings Trend: ISRG's earnings have grown by 15.1% per year over the past 5 years.

Accelerating Growth: ISRG's earnings growth over the past year (60.4%) exceeds its 5-year average (15.1% per year).

Earnings vs Industry: ISRG earnings growth over the past year (60.4%) exceeded the Medical Equipment industry 51.2%.


Return on Equity

High ROE: ISRG's Return on Equity (14.9%) is considered low.


Financial Health

How is Intuitive Surgical's financial position?


Financial Position Analysis

Short Term Liabilities: ISRG's short term assets ($5.7B) exceed its short term liabilities ($1.0B).

Long Term Liabilities: ISRG's short term assets ($5.7B) exceed its long term liabilities ($447.8M).


Debt to Equity History and Analysis

Debt Level: ISRG is debt free.

Reducing Debt: ISRG has not had any debt for past 5 years.

Debt Coverage: ISRG has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ISRG has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Intuitive Surgical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ISRG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ISRG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ISRG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ISRG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ISRG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.0yrs

Average management tenure


CEO

Gary Guthart (55 yo)

11.92yrs

Tenure

US$6,043,362

Compensation

Dr. Gary S. Guthart, Ph D., has been Chief Executive Officer of Intuitive Surgical, Inc. since January 1, 2010 and its President since July 12, 2007. Dr. Guthart served as the Chief Operating Officer at In...


CEO Compensation Analysis

Compensation vs Market: Gary's total compensation ($USD6.04M) is below average for companies of similar size in the US market ($USD11.11M).

Compensation vs Earnings: Gary's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ISRG's management team is seasoned and experienced (7 years average tenure).


Board Members

Experienced Board: ISRG's board of directors are considered experienced (4.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Intuitive Surgical, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Intuitive Surgical, Inc.
  • Ticker: ISRG
  • Exchange: NasdaqGS
  • Founded: 1995
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$114.291b
  • Shares outstanding: 357.24m
  • Website: https://www.intuitive.com

Number of Employees


Location

  • Intuitive Surgical, Inc.
  • 1020 Kifer Road
  • Sunnyvale
  • California
  • 94086-5304
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/02 23:30
End of Day Share Price2021/12/02 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.